Glucotrack Inc (GCTK) Stock Price, Quote & News

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 842 7715

Website: glucotrack.com

Address:

301 Route 17 North, Suite 800, Rutherford, United States

AllInConviction Oct. 22 at 2:53 PM

$GCTK has anybody been able to get in touch with investor relations by phone? If so what is the number?

2 · Reply

Deerslayer1998 Oct. 21 at 1:47 PM

$GCTK moving the wrong way

0 · Reply

KingsOnly Oct. 20 at 9:10 PM

$GCTK moving

0 · Reply

DaBullRunner Oct. 20 at 8:21 PM

$BYND there it goes Loaded the bottom and now more than $1/share up 💰 $RVP loading this before the crowd finds this 🚨 I want $2+ 🎯✅ $HTCR $VRCA $GCTK let’s get it

0 · Reply

Phoenix_Kind6754 Oct. 20 at 12:32 PM

$GCTK Perfect consolidation zone

0 · Reply

Unalloyed Oct. 20 at 1:03 AM

$GCTK Voting on 10/31/25 for approval of 20 million shares to Sixth Borough Capital Fund https://www.sec.gov/Archives/edgar/data/1506983/000149315225016777/formdef14a.htm

1 · Reply

Unalloyed Oct. 20 at 1:02 AM

$GCTK 20 million shares to dump https://www.sec.gov/Archives/edgar/data/1506983/000149315225017452/forms-1a.htm

0 · Reply

Unalloyed Oct. 20 at 1:00 AM

$GCTK

0 · Reply

Unalloyed Oct. 20 at 12:58 AM

$GCTK

0 · Reply

StockChiefs Oct. 12 at 5:47 PM

MTEX has only 600k shares outstanding and started to make its move up Friday! Don't miss MTEX . I would rather buy before they run 200% up.. 💎 Spiked towards $15 recently . Looks like once people find MTEX we could see a squeeze up again! $BHAT $BDRX $QNRX $GCTK have low floats!

0 · Reply

Glucotrack to Participate in the Q3 Virtual Investor Summit

Aug 14, 2025, 4:05 PM EDT - 2 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 6, 2025, 8:30 AM EDT - 2 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Jul 31, 2025, 8:30 AM EDT - 3 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Glucotrack Announces Repurchase of Series A Warrants

Jun 25, 2025, 10:40 AM EDT - 4 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 8:30 AM EDT - 4 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 12, 2025, 9:05 AM EDT - 4 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 4, 2025, 8:30 AM EDT - 5 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

May 28, 2025, 8:30 AM EDT - 5 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 20, 2025, 8:30 AM EDT - 5 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 14, 2025, 5:10 PM EDT - 5 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 13, 2025, 8:01 AM EDT - 5 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Apr 16, 2025, 8:00 AM EDT - 6 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 3, 2025, 8:01 AM EDT - 7 months ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Mar 31, 2025, 5:00 PM EDT - 7 months ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19, 2025, 8:01 AM EDT - 7 months ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Feb 26, 2025, 8:01 AM EST - 8 months ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 4, 2025, 12:24 PM EST - 9 months ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 8:01 AM EST - 9 months ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Jan 29, 2025, 9:00 AM EST - 9 months ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 21, 2025, 8:01 AM EST - 9 months ago

Glucotrack Announces ISO 13485:2016 Certification

Jan 15, 2025, 8:01 AM EST - 10 months ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 7, 2025, 4:05 PM EST - 10 months ago

Glucotrack to Present at TechBio Showcase™ 2025

Dec 3, 2024, 8:30 AM EST - 11 months ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 2, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Apr 22, 2024, 2:10 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 2, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Mar 12, 2024, 9:30 AM EDT - 1 year ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Feb 27, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 13, 2024, 9:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

Jan 2, 2024, 12:33 PM EST - 1 year ago

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Nov 30, 2023, 5:39 PM EST - 2 years ago

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Nov 13, 2023, 9:00 AM EST - 2 years ago

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

Oct 12, 2023, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Aug 31, 2023, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Aug 28, 2023, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

AllInConviction Oct. 22 at 2:53 PM

$GCTK has anybody been able to get in touch with investor relations by phone? If so what is the number?

2 · Reply

Deerslayer1998 Oct. 21 at 1:47 PM

$GCTK moving the wrong way

0 · Reply

KingsOnly Oct. 20 at 9:10 PM

$GCTK moving

0 · Reply

DaBullRunner Oct. 20 at 8:21 PM

$BYND there it goes Loaded the bottom and now more than $1/share up 💰 $RVP loading this before the crowd finds this 🚨 I want $2+ 🎯✅ $HTCR $VRCA $GCTK let’s get it

0 · Reply

Phoenix_Kind6754 Oct. 20 at 12:32 PM

$GCTK Perfect consolidation zone

0 · Reply

Unalloyed Oct. 20 at 1:03 AM

$GCTK Voting on 10/31/25 for approval of 20 million shares to Sixth Borough Capital Fund https://www.sec.gov/Archives/edgar/data/1506983/000149315225016777/formdef14a.htm

1 · Reply

Unalloyed Oct. 20 at 1:02 AM

$GCTK 20 million shares to dump https://www.sec.gov/Archives/edgar/data/1506983/000149315225017452/forms-1a.htm

0 · Reply

Unalloyed Oct. 20 at 1:00 AM

$GCTK

0 · Reply

Unalloyed Oct. 20 at 12:58 AM

$GCTK

0 · Reply

StockChiefs Oct. 12 at 5:47 PM

0 · Reply

VizTheWin Oct. 10 at 1:25 AM

$GCTK Ho-Lee-Sheet, hardest gaping of my life. Just strolling down memory lane.

0 · Reply

_CircuitBreaker Oct. 9 at 11:25 PM

Keep a close watch on CMCT! $TUYA $GCTK $AMPG $MRX ..

0 · Reply

_CircuitBreaker Oct. 9 at 10:39 PM

Keep a close watch on CMCT! ITS MOVING!! $JZ $JFBR $GCTK $CBIO <

0 · Reply

Nb713 Oct. 9 at 1:17 PM

$GCTK 1 million outstanding shares is required for nasdaq compliance. The dilution is necessary if they want to obtain compliance for nasdaq listing. Looks to me like it will be slowly done over the course of 24 months.

1 · Reply